ADL
PCRX icon

Asset Dedication LLC’s Pacira BioSciences PCRX Stock Holding History

Asset Dedication LLC’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44
Closed -$2K – 414
2016
Q3 		$2K Buy
+44
New +$1.72K ﹤0.01% 388
2016
Q1 		– Sell
-844
Closed -$65K – 577
2015
Q4 		$65K Buy
+844
New +$47.8K 0.04% 213

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Asset Dedication LLC's PCRX Position: Q4 2016 in Review

Asset Dedication LLC sold out of Pacira BioSciences (PCRX) in Q4 2016, closing a stake of 44 shares — an estimated $2K sold.

Asset Dedication LLC first reported a position in PCRX in Q4 2015 and held it in 2 quarters. The position peaked at $65K in Q4 2015. 182 funds tracked by Wall St. Rank hold PCRX as of Q4 2016.

  • Asset Dedication LLC reported no remaining Pacira BioSciences position as of Q4 2016 after selling out during the quarter.
  • Asset Dedication LLC sold 44 Pacira BioSciences shares in Q4 2016, an estimated $2K.
  • Asset Dedication LLC first reported a position in Pacira BioSciences in Q4 2015 and held it in 2 quarters.
  • Asset Dedication LLC's Pacira BioSciences position peaked at $65K in Q4 2015.
  • 182 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2016.

Based on Asset Dedication LLC's 13F filing for Q4 2016, filed 17 Jan 2017.